Table 3.
Determinant factors of time to reach the normal range of CD4 count among adult HIV patients who initiated ART in Felege Hiwot Referral Hospital, 2010–2014
| Characteristics | Hazard ratio (95% CI) |
|---|---|
| Baseline age in years | 0.980 (0.966, 0.9941) |
| Sex | |
| Female | 1.0 |
| Male | 0.747 (0.577, 0.968) |
| Baseline functional status | |
| Working | 1.0 |
| Ambulatory | 1.005 (0.742, 1.362) |
| Bedridden | 0.910 (0.441, 1.879) |
| Baseline WHO clinical stage | |
| Stage I | 1.0 |
| Stage II | 1.128 (0.593, 2.146) |
| Stage III | 1.567 (0.887, 2.769) |
| Stage IV | 1.514 (0.776, 2.952) |
| First treatment class | |
| AZT-3TC | 1.0 |
| D4t-3TC | 1.223 (0.950, 1.575) |
| D4t (30) | 1.243 (0.672, 2.298) |
| Baseline CD4 count | 1.006 (1.005, 1.008) |
| P | 1.186 (1.082, 1.299) |
| Theta | 0.052 (0.005, 0.551) |
P is the shape parameter of Weibull distribution; Theta is the parameter for the frailty